These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12583191)

  • 1. [Effect of sinamine on withdrawal symptom and neurotransmitter of morphine-dependent rats].
    Wang C; Mo Z; Zhu Q; Wen L
    Zhong Yao Cai; 2002 May; 25(5):337-9. PubMed ID: 12583191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the detoxification of alcohol extracts from orientvine and its effective component on withdrawal syndromes of morphine].
    Zhang GM; Mo ZX; Wang CY
    Zhong Yao Cai; 2009 Sep; 32(9):1414-8. PubMed ID: 20034221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats.
    Iwamoto ET; Ho IK; Way EL
    J Pharmacol Exp Ther; 1973 Dec; 187(3):588-67. PubMed ID: 4797745
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunization with neuromediators (serotonin, dopamine, noradrenaline) conjugated with a protein suppresses the morphine abstinence syndrome].
    Evseev VA; Trekova NA; Basharova LA; Vetrile LA
    Biull Eksp Biol Med; 1995 May; 119(5):526-9. PubMed ID: 7579252
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotonin and dopamine turnover after acute and chronic morphine administration.
    Papeschi R; Theiss P; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1017-9. PubMed ID: 4408355
    [No Abstract]   [Full Text] [Related]  

  • 6. Yulangsan polysaccharide attenuates withdrawal symptoms and regulates the NO pathway in morphine-dependent rats.
    Chen C; Nong Z; Huang J; Chen Z; Zhang S; Jiao Y; Chen X; Huang R
    Neurosci Lett; 2014 Jun; 570():63-8. PubMed ID: 24747687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral expression of opiate withdrawal is altered after prefrontocortical dopamine depletion in rats: monoaminergic correlates.
    Espejo EF; Serrano MI; Caillé S; Stinus L
    Neuropsychopharmacology; 2001 Aug; 25(2):204-12. PubMed ID: 11425504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
    Fuertes G; Laorden ML; Milanés MV
    Neuroendocrinology; 2000 Jan; 71(1):60-7. PubMed ID: 10644900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain-dependent differences in responses to chronic administration of morphine: lack of relationship to brain catecholamine levels in mice.
    Reinhard JF; Kosersky DS; Peterson GR
    Life Sci; 1976 Nov; 19(9):1413-20. PubMed ID: 1033447
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain serotonin turnover in morphine tolerant and dependent mice.
    Shen FH; Loh HH; Way EL
    J Pharmacol Exp Ther; 1970 Nov; 175(2):427-34. PubMed ID: 5529726
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of the immunostimulant, levamisole, on opiate withdrawal and levels of endogenous opiate alkaloids and monoamine neurotransmitters in rat brain.
    Spector S; Munjal I; Schmidt DE
    Neuropsychopharmacology; 1998 Nov; 19(5):417-27. PubMed ID: 9778663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic morphine treatment and withdrawal increase extracellular levels of norepinephrine in the rat bed nucleus of the stria terminalis.
    Fuentealba JA; Forray MI; Gysling K
    J Neurochem; 2000 Aug; 75(2):741-8. PubMed ID: 10899950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of L-tryptophan for correction of disbalance of central neurotransmitters in morphine withdrawal syndrome].
    Razvodovskiĭ IuE; Doroshenko EM; Selevich MI
    Eksp Klin Farmakol; 2003; 66(1):12-6. PubMed ID: 12683073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotransmitter mechanisms of morphine withdrawal syndrome.
    Lelevich SV; Lelevich VV; Novokshonov AA
    Bull Exp Biol Med; 2009 Aug; 148(2):184-7. PubMed ID: 20027323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nialamide and reserpine on brain free amino acids of rat dependent on and withdrawn from morphine.
    Koyuncuoglu H; Güngör M
    Arzneimittelforschung; 1975 Nov; 25(11):1762-6. PubMed ID: 1243083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J; Papeschi R; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract]   [Full Text] [Related]  

  • 17. Clonidine reverses the increased norepinephrine turnover during morphine withdrawal in rats.
    Laverty R; Roth RH
    Brain Res; 1980 Jan; 182(2):482-5. PubMed ID: 7188872
    [No Abstract]   [Full Text] [Related]  

  • 18. [Regulation of the central opioidergic nervous system on the emotional state of anxiety and its possible mechanisms].
    Zhang HT
    Sheng Li Ke Xue Jin Zhan; 1997 Jan; 28(1):41-4. PubMed ID: 10921076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthesis rate and turnover time of 5-hydroxy-tryptamine in brains of rats treated chronically with morphine.
    Bhargava HN
    Br J Pharmacol; 1979 Feb; 65(2):311-7. PubMed ID: 570072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats.
    Acquas E; Carboni E; Di Chiara G
    Eur J Pharmacol; 1991 Jan; 193(1):133-4. PubMed ID: 1646728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.